In this article in Neurology Today, two scientists – Rosa Rademakers, PhD, and Bryan Traynor, MD, PhD – who started their careers studying very different diseases, ended up at the same genetic address and making a discovery that has changed conventional wisdom about two seemingly disparate conditions: frontotemporal degeneration (FTD) and amyotrophic lateral sclerosis (ALS). They discuss their separate efforts and findings here.